Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITAL: Paricalcitol for Albuminuria in Diabetic Nephropathy
NCT00421733Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Dec 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of paricalcitol oral solution in diabetic nephropathy (DN), sponsored by Abbott Laboratories. Started Dec 2006; status: completed.
02
Drugs
paricalcitol oral solution
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00421733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421733.